View Cart (0 items)

Items Tagged with 'teva pharmaceuticals'

ARTICLES

Teva to end cancer, women's health research

Generic drugmaker Teva Pharmaceutical Industries Ltd. has decided to stop research and development in a number of areas, including oncology and women's health, as part of efforts to cut costs.
Read More

Teva recalls 39,000 bottles of drug products due to manufacturing standards violations

The recalled production includes 2,532 bottles of anti-diabetes drug glyburide, which are being pulled off the U.S. market due to deviations from Current Good Manufacturing Practice.
Read More

Teva's application for patent extension on Copaxone rejected

The U.S. Patent and Trademark Office has rejected the request from Israeli pharma giant Teva Pharmaceuticals to have its patent protection on Copaxone extended until September 2015.
Read More